Cargando…
Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development
Nicotine exerts its reinforcing actions via activating the nicotinic acetylcholine receptors (nAChRs). Among an increasing number of nAChR subtypes, the α4β2 and α7 nAChRs are the two major ones, accounting for about 95% of the whole nAChR population in brain. Research findings from our own laborato...
Autores principales: | Ramachandran Nair, Lakshmi, Liu, Xiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688641/ https://www.ncbi.nlm.nih.gov/pubmed/31404286 |
Ejemplares similares
-
Partial nicotinic acetylcholine (α4β2) agonists as promising new medications for smoking cessation
por: Singh, J., et al.
Publicado: (2008) -
Acetylcholine receptors in the retinas of the α7 nicotinic acetylcholine receptor knockout mouse
por: Smith, Marci L., et al.
Publicado: (2014) -
Targeting α7 nicotinic acetylcholine receptors for chronic pain
por: Zhou, Ya-Qun, et al.
Publicado: (2022) -
Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation
por: Mohamed, Tasnim S., et al.
Publicado: (2015) -
Menthol Binding and Inhibition of α7-Nicotinic Acetylcholine Receptors
por: Ashoor, Abrar, et al.
Publicado: (2013)